Skip to main content
Veterinary Medicines

EQUIP EHV 1,4 sospensione iniettabile per cavalli e ponies

Authorised
  • Equine herpesvirus 4, strain 405/76, Inactivated
  • Equine herpesvirus 1, strain 438/77, Inactivated

Product identification

Medicine name:
EQUIP EHV 1,4 sospensione iniettabile per cavalli e ponies
Active substance:
  • Equine herpesvirus 4, strain 405/76, Inactivated
  • Equine herpesvirus 1, strain 438/77, Inactivated
Target species:
  • Horse
  • Horse (pony)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Equine herpesvirus 4, strain 405/76, Inactivated
    1.00
    relative potency
    /
    1.00
    unit(s)
  • Equine herpesvirus 1, strain 438/77, Inactivated
    1.00
    relative potency
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
    • Horse (pony)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI05AA05
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Italia S.r.l
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 15/05/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."